To our Team Members, Healthcare Community Partners, and Friends of CDI: 2021 was an informative year. The world continues to navigate a new and ever-changing set of circumstances caused by a global health pandemic. While it’s clear that we’ve made meaningful progress at the worldwide level to diminish the rampant effects of this virus, it’s…
CDI is proud to announce it will sponsor an upcoming Dietitian Deep Dive on Small Intestinal Bacterial Overgrowth (SIBO). Nationally recognized dietitians Kate Scarlata, MPH, RDN, LDN, and Erin Judge, RDN, LDN, CPT, will lead the 3-part SIBO Workshop Series. Registration is now open for the live versions of the SIBO series, which will take…
Salem, Mass. – June 29, 2021 – Commonwealth Diagnostics International, Inc. (CDI) is pleased to announce that two of its cofounders, Craig Strasnick and Gray W. Rifkin, were honored recently amongst their peers in both business and healthcare. Strasnick, CDI President and CEO, was named to the Forbes Next 1000 list of upstart entrepreneurs redefining…
Salem, Mass. – May 21, 2021 – Over the past 10 years, Commonwealth Diagnostics International, Inc. (CDI) leadership team has worked closely with industry stakeholders to support the gastroenterology (GI) community. Today, CDI is pleased to announce it has expanded partnerships with several industry and research partners both in the United States and abroad, including…
Digestive Disease Week® (DDW®) will feature 2,000+ oral abstracts and ePoster presentations and 300 original lectured sessions across 17 different tracks as well as a virtual exhibit hall, product theaters, and Satellite Symposia. To break down the newest trends and hottest topics discussed during the 3-day virtual event, CDI and MyGiHealth are pleased to announce…
Maximum out-of-pocket cost for first clinically validated IBS blood test also to be reduced, making it the most affordable IBS diagnostic test on the market Salem, Mass. – February 3, 2021 – For too long millions of patients requiring a simple and reliable blood test for Irritable Bowel Syndrome (IBS) have been met with soaring…
A Letter from CDI President & CEO Craig Strasnick To our Healthcare Partners and Friends of CDI, As we begin the New Year, we wanted to take a moment to reflect on the unprecedented 2020 and communicate how we are going to continue to align with the needs of our provider partners and their patients…
We are excited to announce that our enhanced website is now live with a streamlined, modern design, improved functionality, and easy access to essential information to help providers make well-informed decisions about diagnosing and treating functional GI disorders. Check out some of the new website features: Enriched solution pages that include testing information, instructions for use…
The COVID-19 pandemic has played a major role in the medical field and has altered the lives of patients’ throughout the world. Commonwealth Diagnostics International (CDI) co-hosted Epicured’s Partners in Health November 2020 Clinical Webinar featuring a panel of Gastroenterology experts who explored trends and best practices for diagnosing and treating functional GI Disorders in a…
Commonwealth Diagnostics International, Inc (CDI) has renewed their commitment to the Rome Foundation, an independent 501(c)3 organization whose mission is to improve the lives of people with functional GI disorders. The foundation provides support for activities geared towards data and educational information, which assists in the diagnosis and treatment of Disorders of Gut Brain Interactions. Millions of…
